"Prothrombin Time" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.
| Descriptor ID |
D011517
|
| MeSH Number(s) |
E01.370.225.625.115.610 E05.200.625.115.610 G09.188.680
|
| Concept/Terms |
Prothrombin Time- Prothrombin Time
- Prothrombin Times
- Time, Prothrombin
- Times, Prothrombin
|
Below are MeSH descriptors whose meaning is more general than "Prothrombin Time".
Below are MeSH descriptors whose meaning is more specific than "Prothrombin Time".
This graph shows the total number of publications written about "Prothrombin Time" by people in this website by year, and whether "Prothrombin Time" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 3 | 3 |
| 2017 | 7 | 12 | 19 |
| 2018 | 1 | 9 | 10 |
| 2019 | 1 | 10 | 11 |
| 2020 | 0 | 22 | 22 |
| 2021 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Prothrombin Time" by people in Profiles.
-
COVID-19-related laboratory coagulation findings. Int J Lab Hematol. 2021 Jul; 43 Suppl 1:36-42.
-
Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia. PLoS One. 2021; 16(6):e0252939.
-
A predictive score for progression of COVID-19 in hospitalized persons: a cohort study. NPJ Prim Care Respir Med. 2021 06 03; 31(1):33.
-
Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population. Sensors (Basel). 2021 Apr 09; 21(8).
-
Severe COVID-19 and coagulopathy: A systematic review and meta-analysis. Ann Acad Med Singap. 2021 04; 50(4):325-335.
-
Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy. Anaesth Crit Care Pain Med. 2021 06; 40(3):100841.
-
Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities. Sci Rep. 2021 01 19; 11(1):1793.
-
Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia. Curr Med Res Opin. 2021 01; 37(1):21-25.
-
Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19. Medicina (Kaunas). 2020 Dec 03; 56(12).
-
Analysis of factors for disease progression in 61 patients with COVID-19 in Xiaogan, Hubei, China. Eur Rev Med Pharmacol Sci. 2020 12; 24(23):12490-12499.